Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
national blog main
national top stories
9
×
new york blog main
new york top stories
boston blog main
boston top stories
fda
san diego blog main
san diego top stories
san francisco top stories
biotech
drugs
national
san francisco blog main
abbvie
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
merck
pfizer
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
akcea therapeutics
boston
cancer
eli lilly
genentech
inotersen
new york
What
approved
9
×
fda
9
×
drug
new
medicine
disease
friday
oks
patients
treatment
alnylam
genetic
gets
late
medicines
nod
oral
specifically
therapy
time
treat
acorda
adults
afternoon
agency
ago
aimmune
akcea
allergan
allergy
alnylam’s
amyloidosis
approval
atrophy
attr
available
awarded
battle
bio
brexanolone
Language
unset
Current search:
fda
×
approved
×
" national top stories "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug